Xenetic Biosciences, Inc. XBIO
NASDAQ · United States · Health Technology
$2.21-0.11 (-4.74%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.41 | — | — | $660.60K | — | +8.4%$2.85→$3.09 |
| Q4 2025 | 2026-03-12 | -0.22 | -0.52 | +57.7% | — | — | +6.8%$2.63→$2.81 |
| Q4 2024 | 2025-03-18 | -0.68 | -0.20 | -240.0% | — | — | — |
| Q4 2023 | 2024-03-21 | -0.77 | -0.87 | +11.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.